MENS Stock Analysis: Buy, Sell, or Hold?
MENS - Jyong Biotech Ltd. Ordinary Shares
$2.36
-0.35 (-12.92%)
▼
5d:
+4.42%
30d:
+35.63%
90d:
+3.96%
HOLD
MODERATE Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
16d
Get Alerted When MENS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MENS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MENS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MENS is currently trading at $2.36, which is considered slightly high relative to its 30-day fair value range of $1.82 to $2.44.
Technical Outlook: Technically, MENS is showing sideways momentum. Immediate support is located at $2.15, while resistance sits at $2.75. Short-term momentum is weak, with the stock down 12.9% recently.
Market Sentiment: MENS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MENS is showing sideways momentum. Immediate support is located at $2.15, while resistance sits at $2.75. Short-term momentum is weak, with the stock down 12.9% recently.
Market Sentiment: MENS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.82 -
$2.44
Company Quality Score
54/100
(HOLD)
Options IV Signal
100th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
54.5%
All Signals
- BEARISH: Options expensive (IV 100th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-12.9%)
Trading Range Analysis
30-Day Trading Range
$1.82 -
$2.44
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$0.60
(25.3%)
Support & Resistance Levels
Support Level
$2.15
Resistance Level
$2.75
Current Trend
Sideways
Technical data as of
Jul 24, 2026
Fundamental Context
Share & Embed Analysis
Last updated: July 26, 2026 11:58 PM ET
Data refreshes hourly during market hours. Next update: 12:58 AM
Data refreshes hourly during market hours. Next update: 12:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MENS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 53 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 57 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 51 HOLD |
|
CNTA
Centessa Pharmaceuticals… |
STRONG BUY
11 analysts |
$44 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$39 | 53 HOLD |